Bloomage Biotechnology Corp Ltd Income Statement - Bloomage Biotechnology Corp Ltd - Alpha Spread

Bloomage Biotechnology Corp Ltd
SSE:688363

Watchlist Manager
Bloomage Biotechnology Corp Ltd Logo
Bloomage Biotechnology Corp Ltd
SSE:688363
Watchlist
Price: 80.45 CNY 14.11% Market Closed
Market Cap: 38.8B CNY
Have any thoughts about
Bloomage Biotechnology Corp Ltd?
Write Note

Income Statement

Earnings Waterfall
Bloomage Biotechnology Corp Ltd

Revenue
5.8B CNY
Cost of Revenue
-1.6B CNY
Gross Profit
4.2B CNY
Operating Expenses
-3.6B CNY
Operating Income
592.5m CNY
Other Expenses
-82.8m CNY
Net Income
509.7m CNY

Income Statement
Bloomage Biotechnology Corp Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
1 263
N/A
1 397
+11%
1 512
+8%
1 687
+12%
1 886
+12%
1 898
+1%
2 024
+7%
2 194
+8%
2 633
+20%
3 042
+16%
3 622
+19%
4 049
+12%
4 948
+22%
5 426
+10%
5 947
+10%
6 256
+5%
6 359
+2%
6 409
+1%
6 499
+1%
6 260
-4%
6 076
-3%
6 131
+1%
5 811
-5%
Gross Profit
Cost of Revenue
(254)
(300)
(302)
(348)
(387)
(412)
(442)
(451)
(506)
(610)
(771)
(902)
(1 115)
(1 268)
(1 390)
(1 472)
(1 479)
(1 592)
(1 677)
(1 687)
(1 655)
(1 682)
(1 603)
Gross Profit
1 010
N/A
1 096
+9%
1 210
+10%
1 338
+11%
1 498
+12%
1 486
-1%
1 581
+6%
1 743
+10%
2 127
+22%
2 432
+14%
2 851
+17%
3 147
+10%
3 833
+22%
4 158
+8%
4 556
+10%
4 784
+5%
4 881
+2%
4 818
-1%
4 823
+0%
4 573
-5%
4 421
-3%
4 450
+1%
4 208
-5%
Operating Income
Operating Expenses
(510)
(553)
(623)
(723)
(811)
(832)
(943)
(1 069)
(1 384)
(1 642)
(2 000)
(2 278)
(2 957)
(3 222)
(3 542)
(3 764)
(3 805)
(3 742)
(3 795)
(3 680)
(3 722)
(3 713)
(3 616)
Selling, General & Administrative
(467)
(518)
(570)
(652)
(726)
(752)
(867)
(997)
(1 303)
(1 522)
(1 871)
(2 139)
(2 765)
(3 004)
(3 295)
(3 453)
(3 487)
(3 506)
(3 527)
(3 424)
(3 344)
(3 273)
(3 161)
Research & Development
(50)
(59)
(70)
(77)
(81)
(105)
(116)
(134)
(130)
(151)
(188)
(238)
(269)
(327)
(357)
(369)
(366)
(390)
(395)
(388)
(405)
(459)
(460)
Depreciation & Amortization
(18)
(12)
(14)
0
(27)
0
0
0
(28)
0
0
0
(55)
0
0
0
(73)
0
0
0
(104)
0
0
Other Operating Expenses
24
35
31
6
23
25
41
63
77
32
60
99
132
109
111
58
122
154
128
133
131
19
5
Operating Income
499
N/A
544
+9%
587
+8%
616
+5%
687
+12%
654
-5%
638
-2%
674
+6%
743
+10%
790
+6%
851
+8%
869
+2%
876
+1%
936
+7%
1 015
+8%
1 020
+1%
1 076
+5%
1 076
0%
1 028
-4%
893
-13%
699
-22%
737
+5%
592
-20%
Pre-Tax Income
Interest Income Expense
25
19
20
16
13
40
51
46
14
29
13
19
31
23
52
58
61
62
46
32
34
29
15
Non-Reccuring Items
(0)
(0)
(0)
(0)
(1)
0
0
0
0
0
0
(2)
(5)
0
(0)
2
(1)
0
0
0
(27)
0
0
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
2
0
0
Total Other Income
(9)
(12)
(4)
(2)
3
5
5
5
1
3
3
(0)
(11)
(15)
(19)
(16)
0
(2)
2
2
(7)
(5)
(5)
Pre-Tax Income
515
N/A
550
+7%
603
+9%
629
+4%
701
+11%
699
0%
694
-1%
725
+4%
759
+5%
822
+8%
867
+5%
885
+2%
890
+1%
943
+6%
1 048
+11%
1 065
+2%
1 136
+7%
1 136
0%
1 076
-5%
927
-14%
702
-24%
761
+8%
603
-21%
Net Income
Tax Provision
(91)
(95)
(103)
(109)
(117)
(114)
(107)
(119)
(114)
(133)
(128)
(123)
(115)
(122)
(165)
(176)
(175)
(171)
(160)
(126)
(119)
(135)
(101)
Income from Continuing Operations
424
456
500
521
585
586
587
606
645
689
738
762
776
821
883
889
961
965
916
801
583
625
502
Income to Minority Interest
0
0
1
1
1
1
1
1
1
1
1
2
7
9
12
16
10
7
6
7
10
10
8
Net Income (Common)
424
N/A
456
+8%
500
+10%
521
+4%
586
+12%
586
+0%
588
+0%
607
+3%
646
+6%
690
+7%
739
+7%
764
+3%
782
+2%
830
+6%
895
+8%
904
+1%
971
+7%
972
+0%
922
-5%
808
-12%
593
-27%
635
+7%
510
-20%
EPS (Diluted)
0.98
N/A
1.05
+7%
1.16
+10%
1.21
+4%
1.34
+11%
1.22
-9%
1.22
N/A
1.26
+3%
1.35
+7%
1.44
+7%
1.54
+7%
1.59
+3%
1.63
+3%
1.73
+6%
1.83
+6%
1.88
+3%
2.01
+7%
2.03
+1%
1.9
-6%
1.69
-11%
1.23
-27%
1.32
+7%
1.06
-20%

See Also

Discover More